+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Gel Column Agglutination Test system market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • ID: 5012712
  • Report
  • January 2022
  • Region: Global
  • 115 Pages
  • Mordor Intelligence

FEATURED COMPANIES

  • 3B scientific
  • Bio-Rad Laboratories Inc.
  • Grifols
  • Mira Vista Labs
  • QIAGEN NV
  • Thermo Fisher Scientific

The gel column agglutination test system market is expected to register a CAGR of 5.5% during the forecast period. Health awareness among the population and high health expenditure by the government are some of the factors driving the overall market. The gel column agglutination test gives high accuracy and more rapid results that will further lead to the adoption of these tests and boost the revenue growth of the market. These tests are widely used in the pharmaceutical industry for diagnostic purposes. Moreover, several applications in the field of research laboratories are also propelling the market as these tests are easy to conduct, the basic principle is being used wherein based on the size, the gel column separates agglutinated blood from non-agglutinated red blood cells leading to the high demand of this systems in the laboratories. Furthermore, technological advancements, increasing diagnostic centers, and hospital blood bank assists may also contribute to the gel column agglutination test market.



Key Market Trends


Benchtop ​Segment is Expected to Hold largest Market Share in the Gel Column Agglutination Test System market


The Benchtop gel column agglutination system is expected to hold the largest share attributing to its convenience, ease of use with a faster performance which promotes the adoption of these types for testing in the pharmaceutical industries. Gel Column agglutination test system comprises several tests such as antibody screening, Serology test, direct antiglobulin test (DAT), RH type test, ABO test which is extensively used for diagnostic purposes and has been major factors for the segment growth.



In addition, with the increasing R&D expenditure worldwide, and several applications with this system such as blood grouping, red cell antibody detection, and identification and other serological applications, results in propelling the growth of the gel column agglutination test system market.



North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period


North America is expected to hold a major market share in the global gel column agglutination test system market due to the growing number of diagnostic centers and high health awareness in this region. Moreover, technological advancements in the gel column agglutination testing system are leading to the increasing adoption of these testing methods which further lead to dominant the market in this region. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.



Competitive Landscape


The market studied is moderately competitive and there are several international companies that are having an active presence in this market. Some of the companies which are currently gaining attention include, Bio-Rad Laboratories, Inc., Grifols, QIAGEN, Ortho Clinical Diagnostics, Tulip Diagnostics (P) Ltd, Thermo Fisher Scientific, 3B scientific and Mira Vista Labs.



Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3B scientific
  • Bio-Rad Laboratories Inc.
  • Grifols
  • Mira Vista Labs
  • QIAGEN NV
  • Thermo Fisher Scientific

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Health Awareness and High Health Expenditure
4.2.2 High Accuracy and Rapid Results
4.3 Market Restraints
4.3.1 Cost Effectiveness
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Test Type
5.1.1 Antibody Screening
5.1.2 Serology Test
5.1.3 DAT
5.1.4 Others
5.2 By Type
5.2.1 Portable
5.2.2 Bench-Top
5.3 By End-User
5.3.1 Pharmaceuticals Industry
5.3.2 Hospital Blood Banks
5.3.3 Diagnostic Centers
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bio-Rad Laboratories Inc.
6.1.2 Ortho Clinical Diagnostics
6.1.3 QIAGEN NV
6.1.4 Grifols
6.1.5 Tulip Diagnostics (P) Ltd
6.1.6 Thermo Fisher Scientific
6.1.7 3B scientific
6.1.8 Mira Vista Labs
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Bio-Rad Laboratories Inc.
  • Ortho Clinical Diagnostics
  • QIAGEN NV
  • Grifols
  • Tulip Diagnostics (P) Ltd
  • Thermo Fisher Scientific
  • 3B scientific
  • Mira Vista Labs
Note: Product cover images may vary from those shown

Loading
LOADING...